Regenxbio RGNX EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Regenxbio’s reported figures.
Based on trailing twelve months.
The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regenxbio's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regenxbio's EBITDA margin?
- Regenxbio (RGNX) reported EBITDA margin of -274.6% in Q1 2026.
- How has Regenxbio's EBITDA margin changed year-over-year?
- Regenxbio's EBITDA margin decreased by 204.4% year-over-year, from -90.2% to -274.6%.
- What is the long-term trend for Regenxbio's EBITDA margin?
- Over 5 years (2020 to 2025), Regenxbio's EBITDA margin has grown at a 3.6% compound annual growth rate (CAGR), from -71.7% to -85.4%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.